With Bill Ackman's posts, one of the world’s most prominent investors is intensifying a dispute between a doctor and ...

Verily CEO Stephen Gillett told staff that the company's Granular insurance business is to be acquired by Elevance Health.

Verily, Alphabet Inc.'s health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, ...

Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to the company's management. Please go ahead.Nathan Rich -- Vice President, ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target is $463.00. Whit Mayo has given his Buy rating due ...

Alphabet's Verily is selling its subsidiary, Granular Insurance Company, to Elevance Health. Verily launched Granular in 2020 with financial backing from the commercial insurance unit of the Swiss Re ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per ...

Analysts' ratings for Elevance Health (NYSE:ELV) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates ...

Elevance Health shares fell 21% in 2024 due to weak fundamental performance, with revenue growing low-single-digits and flat earnings per share. The company is expanding its non-insurance ...

Unless the payments are sustainable, the dividend yield doesn't mean too much. Before making this announcement, Elevance Health was easily earning enough to cover the dividend. As a result, a large ...